Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ultradian Subcutaneous Hydrocortisone Infusion in Addison Disease and Congenital Adrenal Hyperplasia

NCT02096510 is registered in ClinicalTrials.gov with Haukeland University Hospital as lead sponsor.

NCT NCT02096510
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02096510 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ultradian Subcutaneous Hydrocortisone Infusion in Addison Disease and Congenital Adrenal Hyperplasia
Lead sponsor
Haukeland University Hospital
Phase
Phase 1/2
Overall status
Completed
Start date
March 27, 2014
Completion date
December 31, 2017
Enrollment
8 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

addison disease, adrenal hyperplasia congenital